HeartSciences (HSCS) Net Cash Flow (2021 - 2026)
HeartSciences filings provide 6 years of Net Cash Flow readings, the most recent being $1.4 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 199.34% to $1.4 million in Q1 2026 year-over-year; TTM through Jan 2026 was $800513.0, a 117.87% increase, with the full-year FY2025 number at -$4.7 million, down 213.56% from a year prior.
- Net Cash Flow hit $1.4 million in Q1 2026 for HeartSciences, up from -$841128.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $7.0 million in Q1 2024 to a low of -$1.5 million in Q2 2025.
- Median Net Cash Flow over the past 5 years was -$475510.0 (2023), compared with a mean of $178038.6.
- The widest YoY moves for Net Cash Flow: up 709.28% in 2024, down 369.1% in 2024.
- HeartSciences' Net Cash Flow stood at -$1.2 million in 2022, then surged by 60.26% to -$475510.0 in 2023, then soared by 39.51% to -$287658.0 in 2024, then crashed by 192.41% to -$841128.0 in 2025, then surged by 271.9% to $1.4 million in 2026.
- The last three reported values for Net Cash Flow were $1.4 million (Q1 2026), -$841128.0 (Q4 2025), and $1.7 million (Q3 2025) per Business Quant data.